High dose of commercial products of kava (Piper methysticum) markedly enhanced hepatic cytochrome P450 1A1 mRNA expression with liver enlargement in rats
Authors:
- Hiroko HashidaHHHiroko Hashida
- Fumio ShimuraFSFumio Shimura
- 1 December 2008
- journal article
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 46 (12) , 3732-3738
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Clinical assessment of CYP2D6‐mediated herb–drug interactions in humans: Effects of milk thistle, black cohosh, goldenseal, kava kava, St. John's wort, andEchinaceaMolecular Nutrition & Food Research, 2008
- Immunohistochemical analysis of expressions of hepatic cytochrome P450 in F344 rats following oral treatment with kava extractExperimental and Toxicologic Pathology, 2007
- In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 phenotypesClinical Pharmacology & Therapeutics, 2005
- Extracts of kava ( Piper methysticum ) induce acute anxiolytic-like behavioral changes in micePsychopharmacology, 2003
- Kava-kava and anxiety: Growing knowledge about the efficacy and safetyLife Sciences, 2002
- Drug points: Hepatitis associated with Kava, a herbal remedy for anxietyBMJ, 2001
- CYP3A4 drug interactions: correlation of 10 in vitro probe substratesBritish Journal of Clinical Pharmacology, 1999
- Background to the ADI/TDI/PTWIRegulatory Toxicology and Pharmacology, 1999
- Ethoxyresorufin-O-deethylase and Porphyrin Analysis in Chicken Embryo Hepatocyte Cultures with a Fluorescence Multiwell Plate ReaderAnalytical Biochemistry, 1993
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970